Consonance Life Sciences
Insider
First SEC filing: May 19, 2021 · Latest: May 19, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 11, 2021 | SRZN | A | 144,667 | · | · | 144,667 Indirect | -50.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2021 | SRZN | D | 144,667 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2021 | SRZN | A | 1,451,000 | · | · | 1,885,000 Indirect | +334.33% | Acquired | (price as of 2026-10-02) |
| Aug. 11, 2021 | SRZN | A | 434,000 | · | · | 434,000 Indirect | · | Acquired | (price as of 2026-10-02) |
| Aug. 11, 2021 | SRZN | D | 1,451,000 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2021 | SRZN | J | 759,000 | · | · | 1,451,000 Indirect | -34.34% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2021 | SRZN | D | 434,000 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 1, 2020 | SRZN | A | 24,000 | · | · | 434,000 Direct | +5.85% | Acquired | (price as of 2026-10-02) |
| Dec. 1, 2020 | SRZN | A | 8,000 | · | · | 144,667 Direct | +5.85% | Acquired | (price as of 2026-10-02) |
| Dec. 1, 2020 | SRZN | P | 24,000 | · | · | 434,000 Direct | +5.85% | Acquired | (price as of 2026-10-02) |
| Dec. 1, 2020 | SRZN | P | 8,000 | · | · | 144,667 Direct | +5.85% | Acquired | (price as of 2026-10-02) |
| Nov. 23, 2020 | SRZN | A | 136,667 | · | · | 136,667 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 23, 2020 | SRZN | A | 410,000 | · | · | 410,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 23, 2020 | SRZN | P | 410,000 | · | · | 410,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 23, 2020 | SRZN | P | 136,667 | · | · | 136,667 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 18, 2020 | SRZN | S | 30,000 | $0.01 | $300 | 2,210,000 Direct | -1.34% | Disposed | 19446.8% (price as of 2026-10-02) |
| Nov. 18, 2020 | SRZN | S | 30,000 | $0.01 | $300 | 2,240,000 Direct | -1.32% | Disposed | 19446.8% (price as of 2026-10-02) |
| Nov. 18, 2020 | SRZN | S | 30,000 | $0.01 | $300 | 2,270,000 Direct | -1.30% | Disposed | 19446.8% (price as of 2026-10-02) |
| Nov. 10, 2020 | SRZN | D | 575,000 | · | · | 2,300,000 Direct | -20.00% | Disposed | (price as of 2026-10-02) |
| Oct. 8, 2020 | SRZN | D | 718,750 | · | · | 2,875,000 Direct | -20.00% | Disposed | (price as of 2026-10-02) |
| Sept. 4, 2020 | SRZN | A | 3,593,750 | $0.01 | $35,938 | 3,593,750 Direct | · | Acquired | 19446.8% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 11, 2021 | SRZN | Warrants [F3] | Common Stock | $11.50 | · | 144,667 | Disposed |
| Aug. 11, 2021 | SRZN | Warrants [F3] | Class A Ordinary Shares | $11.50 | · | 144,667 | Disposed |
| Dec. 1, 2020 | SRZN | Warrant [F1,F5] | Class A Ordinary Shares | $11.50 | · | 8,000 | Acquired |
| Dec. 1, 2020 | SRZN | Warrant [F1,F5] | Class A Ordinary Shares | $11.50 | · | 8,000 | Acquired |
| Nov. 23, 2020 | SRZN | Warrant [F1,F5] | Class A Ordinary Shares | $11.50 | · | 136,667 | Acquired |
| Nov. 23, 2020 | SRZN | Warrant [F1,F5] | Class A Ordinary Shares | $11.50 | · | 136,667 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.